Inventor profile of:

Michael Karin

City:

La Jolla, California

Country:

United States

Published Applications:

37

Last publication date:

2025-09-18

Top Assignees for applications by Michael Karin

The entities that hold a legal rights for patent applications filed by inventor Karin Michael:

Recent patent applications by Karin Michael

Michael Karin from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-18
US20250288542A1
Human necessities

METHODS AND COMPOSITIONS TO TREAT AND PREVENT VIRAL INFECTIONS AND ACUTE RESPIRATORY DISTRESS SYNDROME

#2 | 2025-02-27
US20250064808A1
Human necessities

METHODS FOR THE TREATMENT OF NLRP3 RELATED DISORDERS

#3 | 2024-08-22
US20240279326A1
Chemistry; metallurgy

ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF

#4 | 2023-10-26
US20230341404A1
Physics

TARGETING STROMA-CANCER INTERACTIONS IN CANCER

#5 | 2023-03-02
US20230068698A1
Human necessities

COMBINATION THERAPY FOR CANCER

#6 | 2022-05-05
US20220133770A1
Human necessities

METHODS FOR TREATING MACROPHAGE-MEDIATED DISEASES, AND METHODS OF IDENTIFYING AGENTS USEFUL THEREFORE

#7 | 2021-12-16
US20210386828A1
Human necessities

METHODS FOR ENHANCING CANCER IMMUNOTHERAPY

#8 | 2021-05-27
US20210154222A1
Human necessities

Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor

#9 | 2021-04-08
US20210101970A1
Chemistry; metallurgy

Anti-CXCR5 antibodies and compositions and uses thereof

#10 | 2019-12-26
US20190388454A1
Human necessities

Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor

#11 | 2019-11-21
US20190351003A1
Human necessities

METHODS FOR INHIBITING NONALCOHOLIC STEATOHEPATITIS, NONALCOHOLIC FATTY LIVER DISEASE, AND/OR DE NOVO LIPOGENESIS

#12 | 2019-06-06
US20190169283A1
Chemistry; metallurgy

Anti-CXCR5 antibodies and compositions and uses thereof

#13 | 2018-12-27
US20180369291A1
Human necessities

Hepatocytes with high regenerative capacity for liver repair

#14 | 2018-09-20
US20180264004A1
Human necessities

Chemoimmunotherapy for epithelial cancer

#15 | 2016-12-15
US20160360735A1
Human necessities

Animal model of nash-induced hepatocellular carcinoma and methods for developing specific therapeutics

#16 | 2015-11-12
US20150320020A1
Human necessities

Fibrotic non-human animal, and use thereof

#17 | 2014-03-27
US20140086939A1
Human necessities

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING CANCER

#18 | 2014-03-27
US20140086918A1
Human necessities

Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function

#19 | 2009-04-30
US20090111786A1
Human necessities

Compounds that Prevent Macrophage Apoptosis and Uses Thereof

#20 | 2009-02-26
US20090054524A1
Human necessities

Methods for identifying and using IKK inhibitors

#21 | 2008-11-13
US20080280286A1
Chemistry; metallurgy

Compositions and methods for gene expression

#22 | 2008-10-23
US20080260753A1
Chemistry; metallurgy

Mouse Models of Crohn's Disease and a Method to Develop Specific Therapeutics

#23 | 2008-09-18
US20080227115A1
Physics

Method for detecting the presence of prostate cancer

#24 | 2008-09-04
US20080213817A1
Physics

Enhancement of Th2-Dependent and Inflammatory Response

#25 | 2007-12-06
US20070281328A1
Physics

Methods and compositions for reducing microbial induced apoptosis

#26 | 2007-10-25
US20070248706A1
Human necessities

Compositions and methods for activating Toll-like receptor 4

#27 | 2007-09-06
US20070207137A1
Human necessities

Inhibition of Jun Kinase

#28 | 2007-07-19
US20070166812A1
Chemistry; metallurgy

Gamma subunit of cytokine responsive lkB-alpha kinase complex

#29 | 2007-03-13
US9377795
-

Gamma subunit of cytokine responsive IκB-alpha kinase complex and methods of using same

#30 | 2006-09-14
US20060204525A1
Human necessities

Compositions and methods for preventing and treating anthrax diseases

#31 | 2006-06-22
US20060135603A1
Human necessities

Methods for identifying IκB Kinase (IKK) inhibitors

#32 | 2006-05-30
US10376470
-

Methods for identifying and using IKK inhibitors

#33 | 2006-05-18
US20060105414A1
Human necessities

Inhibition of B-cell maturation and antibody production

#34 | 2006-04-27
US20060089305A1
Human necessities

Compositions and methods for activating toll-like receptor 4

#35 | 2005-11-24
US20050261247A1
Human necessities

Compositions and methods for modulating NH2-terminal Jun Kinase activity

#36 | 2005-03-08
US9861097
-

Oncoprotein protein kinase

#37 | 2005-01-20
US20050013818A1
Physics

Compositions and methods for the suppression of mammary epithelial cell proliferation

InventorID:

703184 ⎘